Medivation Inc (NASDAQ:MDVN) and Astellas Pharma Inc. announced that the U.
Medivation Inc (NASDAQ:MDVN) announced that Marion McCourt will join the company as chief operating officer on February 1, 2016. In this newly created position, …
Medivation Inc (NASDAQ:MDVN) and NanoString Technologies, Inc. (NASDAQ:NSTG) announced they have entered into a collaboration, together with Astellas Pharma Inc.
Medivation Inc (NASDAQ:MDVN) reported its financial results for the third quarter endedSeptember 30, 2015. U.
Analysts are weighing in on the Microbiome-focused company Synthetic Biologics Inc (NYSEMKT:SYN) and biopharmaceutical comapny Medivation Inc (NASDAQ:MDVN), with price targets ranging from 107% to 118% upside. …
After hitting a high of $140 per share in March, Medivation Inc (NASDAQ:MDVN) has been on a downward trend despite nothing but good …
In a research report published Tuesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Medivation Inc (NASDAQ:MDVN) with a price …
Medivation Inc (NASDAQ:MDVN) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced that they have entered into an asset purchase agreement under which Medivation will acquire all …
Medivation Inc (NASDAQ:MDVN) reported its financial results for the second quarter ended June 30, 2015. U.
Medivation Inc (NASDAQ:MDVN) has been in a free fall ever since the ASCO conference at the beginning of June, losing over 20% of its …
